U.S. NeuroSurgical Holdings, Inc.
Other OTCTotal Valuation
U.S. NeuroSurgical Holdings, Inc. carries a market capitalization of 22.16M, placing it among publicly traded companies globally. Its enterprise value stands at 10.40M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 22.16M |
| Enterprise Value | 10.40M |
Share Statistics
U.S. NeuroSurgical Holdings, Inc. currently has 21.41M shares outstanding.
| Shares Outstanding | 21.41M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
| PE Ratio | N/A |
| PS Ratio | N/A |
| PB Ratio | -3.01 |
| P/TBV Ratio | 3.79 |
| P/FCF Ratio | -10.38 |
| P/OCF Ratio | -10.38 |
Financial Position
U.S. NeuroSurgical Holdings, Inc. maintains a current ratio of 73.14, meaning it holds 73.1x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 73.14 |
| Quick Ratio | 72.49 |
| Debt / Equity | 1.51 |
| Debt / EBITDA | -0.04 |
| Interest Coverage | N/A |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -62.73 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Stock Price Statistics
U.S. NeuroSurgical Holdings, Inc.'s stock has gained approximately 47.85714% over the past 52 weeks. The 50-day moving average sits at 0.90, while the 200-day moving average is 0.84.
| Beta (5Y) | N/A |
| 52-Week Price Change | 47.85714% |
| 50-Day Moving Average | 0.90 |
| 200-Day Moving Average | 0.84 |
| Average Volume (20 Days) | N/A |
Income Statement
EBITDA reached -1.73M, while operating income came in at -1.74M.
| Revenue | N/A |
| Gross Profit | N/A |
| Operating Income | -1.74M |
| Pretax Income | -2.17M |
| Net Income | -2.17M |
| EBITDA | -1.73M |
| EBIT | -1.74M |
| Earnings Per Share (EPS) | -0.13 |
Balance Sheet
U.S. NeuroSurgical Holdings, Inc. holds 3.70M in cash and equivalents against 64,000.00 in total debt, resulting in a net debt position of -3.70M. Total book value stands at -4.65M, with working capital of 3.68M providing operational flexibility.
| Cash & Cash Equivalents | 3.70M |
| Total Debt | 64,000.00 |
| Net Debt | -3.70M |
| Equity (Book Value) | -4.65M |
| Book Value Per Share | -0.27 |
| Working Capital | 3.68M |
Cash Flow
U.S. NeuroSurgical Holdings, Inc. produced -1.35M in operating cash flow over the past twelve months.
| Operating Cash Flow | -1.35M |
| Capital Expenditures | N/A |
| Free Cash Flow | -1.35M |
| FCF Per Share | -0.08 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -25.30 |
| FCF Yield | -9.63 |
Scores
U.S. NeuroSurgical Holdings, Inc. posts an Altman Z-Score of 90.34, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 90.34 |